METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA
Clinical trials for METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virus therapy takes on lung cancer after standard treatment fails
Disease control Recruiting nowThis study tests a new approach for people with advanced non-small-cell lung cancer whose disease has worsened after initial chemotherapy and immunotherapy. Participants receive an experimental virus (Olvi-Vec) followed by chemotherapy plus an immunotherapy drug, or the standard …
Matched conditions: METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New combo aims to extend control of advanced lung cancer
Disease control Recruiting nowThis study tests whether a combination of two drugs, cabozantinib and pembrolizumab, can help keep advanced squamous non-small cell lung cancer from growing after initial treatment. About 36 adults whose cancer was controlled after standard chemotherapy plus pembrolizumab will re…
Matched conditions: METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated May 15, 2026 11:55 UTC